
The Mahwah, N.J.-based infusion pump developer announced in an SEC filing that, as of July 18, the Board of Directors eliminated the position of chief technology officer, which Brian Case currently holds. The elimination takes effect on September 16, and Case’s employment with the company will also be terminated.
As part of this announcement, the board of directors created the position of chief operating officer and appointed Christopher Pazdan, currently the company’s senior vice president of operations. His appointment took effect on July 18.
“As we drive forward in our next chapter of innovation and growth, I am thrilled to welcome Chris to the newly created role of Chief Operating Officer. We are focused on delivering on our growth agenda, and believed it was important to bring our cross-functional project teams together under one leader to better serve customer needs. Chris has proven himself as a transformative business leader, consistently delivering measurable results, and inspiring our team with his drive and collaborative approach,” said President and CEO Linda Tharby. “He knows our business and culture well, which will enable him to effectively lead cross functional teams in the launch of key new products and as we continue to expand our leadership position in large volume subcutaneous infusion with new drug therapies. I am confident that he will continue to have a tremendous impact on our long-term success in his new role as COO.”
Prior to joining Koru Medical Systems, Pazdan was vice president of quality assurance at Hill-Rom, where he was responsible for developing and realizing Hill-Rom’s quality assurance mission. He has over 20 years of quality assurance and regulatory affairs experience in the medical technology and pharmaceutical sectors, and he’s also worked for Abbott and BD.
“In my expanded role as chief operating officer I will prioritize a continued focus around implementing technology and innovation strategies that enable KORU Medical to reach its full potential as a drug delivery partner of choice, while also relentlessly meeting the needs of patients and customers.”